Cube Labs SpA MIL:CUBE:
SAID ON WEDNESDAY EUROPEAN PATENT OFFICE APPROVED REQUEST FOR PATENT ON BIODIAPERS
PATENT UNDER TITLE OF "ABSORBENT ARTICLE WITH SYSTEM FOR SEPARATING AND ISOLATING FECES"
Cube Labs Says Patent Request On Biodiapers Was Approved By European Patent Office
On 6ix: 6ix.com/news/cube-labs-says-patent-request-on-biodiapers-was-approved-by-european-patent-office
Earlier from Cube Labs
- Cube Labs Unit Lipovexa Obtains U.S. Patent For New Therapeutic Platform For Treatment Of Metabolic Disorders
- Cube Labs Renews Strategic Partnership With INBB
- Cube Labs Concludes Capital Hike Option Offer, Shares Subscribed For EUR 0.4 Mln
- Italy - Factors to watch on October 27
- Cube Labs To Execute Capital Hike For Up To EUR 5 Mln
Later from Cube Labs
- Cube Labs Unit Rescue Code Granted European Patent For Surgical Device
- Cube Labs Unit Obtains Patent In India For Its Physiological Parameters Measuring System
- Cube Labs Unit DTECH Registers U.S. Patent
- Cube Labs FY25 EBITDA At EUR 586,000
Follow Cube Labs into a list and get an email when it puts out news.
Follow Cube Labs